The company did say they were looking to enrol up to 300 patients for the study. Agree that the trials weren't as comprehensive as they should be. $15 million sounds about right. Agree not all the money needed could be raised in one placement. Let's see what they can do from here on. I still reckon it's worth a punt. Market cap is still small and the capital structure is still very attractive.
worth a punt, page-20
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $43.92K | 3.262M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 12077948 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4057172 | 6 |
View Market Depth
| Last trade - 14.25pm 01/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |